Cosmo Godino1,2*, MD; Guido Parodi3, MD; Shinichi Furuichi1, MD; Azeem Latib1, MD; Rossella Barbagallo4, MD; Omer Goktekin6, MD; Michela Cera1, MD; Ralf Mueller5, MD; Corrado Tamburino4, MD; Eberhard Grube5, MD; Carlo Di Mario6, MD; Bernard Reimers7, MD; Alaide Chieffo1, MD; David Antoniucci3, MD; Antonio Colombo1,2, MD; Giuseppe M. Sangiorgi8, MD
1. Interventional Cardiology Unit, San Raffaele Institute, Milan, Italy; 2. EMO GVM Centro Cuore Columbus, Milan, Italy; 3. Division of Cardiology, Careggi Hospital, Florence, Italy; 4. Clinical Division of Cardiology, Ferrarotto Hospital, Catania, Italy;
Aims: Limited data are available on the long-term outcome following PCI with paclitaxel-eluting stent (PES) implantation in patients with unprotected left main coronary artery (LMCA). The o